Literature DB >> 9726724

Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up.

D Stănescu1, A Sanna, C Veriter, A Robert.   

Abstract

BACKGROUND: Cigarette smoking is the cardinal cause of COPD, but only a relatively small percentage of smokers have development of clinically overt disease.
OBJECTIVES: To identify high-risk subjects and to assess the prognostic significance of "small airways" tests.
SETTING: University teaching hospital.
SUBJECTS: Fifty-six smokers and ex-smokers of mean age 62.5 years (SD, 2.7) with a smoking history of 40.6 (18.9) pack-years were studied at the end of a 13-year follow-up period. MEASUREMENTS: Questionnaire and lung function tests, including static and dynamic lung volumes, airway resistance, maximal expiratory flow rates, and small airways tests, such as nitrogen slope of the alveolar plateau (N2 slope) and closing volume.
RESULTS: Eighty-two percent of subjects with a normal FEV1/vital capacity (VC) ratio at the start of the study (half of them with abnormal results of small airways tests) still had a normal FEV1/VC ratio 13 years later. In the remainder, all but one had final FEV1/VC values >60%. About 80% of subjects with a decreased FEV1/VC at the start (subjects with airflow obstruction) reached at the end of study lower than predicted FEV1/VC values. Only about 10% of these subjects showed an accelerated loss of FEV1, reaching end FEV1/VC values of <45%. Initial N2 slope predicted about 80% of end FEV1 values.
CONCLUSION: Middle-aged smokers are at no evident risk of functional deterioration if their FEV1/VC ratio is normal. This is so even if results of small airways tests are abnormal. A decreased FEV1/VC ratio has no serious implications in itself. Only an associated high N2 slope adds the necessary information to predict a low FEV1. Present data suggest that a subgroup of smokers in their 50s, characterized by a low FEV1/VC ratio and a high N2 slope, are probably the susceptible smokers at high risk for development of COPD.

Entities:  

Mesh:

Year:  1998        PMID: 9726724     DOI: 10.1378/chest.114.2.416

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Closing volume: a reappraisal (1967-2007).

Authors:  Joseph Milic-Emili; Roberto Torchio; Edgardo D'Angelo
Journal:  Eur J Appl Physiol       Date:  2007-01-20       Impact factor: 3.078

2.  Reply: Prognostic value of functional decline in middle-aged smokers.

Authors:  M Bradley Drummond; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2013-05-01       Impact factor: 21.405

3.  Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography.

Authors:  R Yuan; J C Hogg; P D Paré; D D Sin; J C Wong; Y Nakano; A M McWilliams; S Lam; H O Coxson
Journal:  Thorax       Date:  2009-09-03       Impact factor: 9.139

4.  Tidal volume single breath washout of two tracer gases--a practical and promising lung function test.

Authors:  Florian Singer; Georgette Stern; Cindy Thamrin; Oliver Fuchs; Thomas Riedel; Per Gustafsson; Urs Frey; Philipp Latzin
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

Review 5.  Systematic review of the evidence relating FEV1 decline to giving up smoking.

Authors:  Peter N Lee; John S Fry
Journal:  BMC Med       Date:  2010-12-14       Impact factor: 8.775

6.  Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD.

Authors:  Paula Rytilä; Tiina Rehn; Helen Ilumets; Annamari Rouhos; Anssi Sovijärvi; Marjukka Myllärniemi; Vuokko L Kinnula
Journal:  Respir Res       Date:  2006-04-28

Review 7.  Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.

Authors:  Andrea Rossi; Bojana Butorac-Petanjek; Marco Chilosi; Borja G Cosío; Matjaz Flezar; Nikolaos Koulouris; José Marin; Neven Miculinic; Guido Polese; Miroslav Samaržija; Sabina Skrgat; Theodoros Vassilakopoulos; Andrea Vukić-Dugac; Spyridon Zakynthinos; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-29

8.  Non-invasive biomarkers and pulmonary function in smokers.

Authors:  Zoë L Borrill; Kay Roy; Rupert S Vessey; Ashley A Woodcock; Dave Singh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 9.  Techniques of assessing small airways dysfunction.

Authors:  William McNulty; Omar S Usmani
Journal:  Eur Clin Respir J       Date:  2014-10-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.